Systematic analysis of levels of evidence supporting Chinese clinical practice guidelines for gastrointestinal disease

被引:0
|
作者
Han, Ke [1 ]
Zhao, Pengyue [2 ]
Chen, Shimin [3 ]
Bao, Yinghui [3 ]
Li, Boyan [3 ]
Du, Jiajun [4 ]
Wu, Junwei [4 ]
Li, Huikai [1 ]
Chai, Ningli [1 ]
Du, Xiaohui [2 ]
Linghu, Enqiang [1 ]
Liu, Miao [5 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Med Ctr 1, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Med Ctr 1, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Med Ctr 2, Natl Clin Res Ctr Geriatr Dis,Beijing Key Lab Agin, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Lib Grad Sch, Beijing, Peoples R China
[5] Chinese Peoples Liberat Army Gen Hosp, Grad Sch, Dept Anti NBC Med, Beijing, Peoples R China
来源
MED | 2024年 / 5卷 / 09期
基金
国家重点研发计划;
关键词
RECOMMENDATIONS; DISORDERS; ASSOCIATION; STRENGTH; QUALITY; COLLEGE; CANCER;
D O I
10.1016/j.medj.2024.05.006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Clinical practice guidelines (CPGs) inform healthcare decisions and improve patient care. However, an evaluation of guidelines on gastrointestinal diseases (GIDs) is lacking. This study aimed to systematically analyze the level of evidence (LOE) supporting Chinese CPGs for GIDs. Methods: CPGs for GIDs were identified by systematically searching major databases. Data on LOEs and classes of recommendations (CORs) were extracted. According to the Grades of Recommendation, Assessment, Development, and Evaluation system, LOEs were categorized as high, moderate, low, or very low, whereas CORs were classified as strong or weak. Statistical analyses were conducted to determine the distribution of LOEs and CORs across different subtopics and assess changes in evidence quality over time. Findings: Only 27.9% of these recommendations were supported by a high LOE, whereas approximately 70% were strong recommendations. There was a significant disparity among different subtopics in the proportion of strong recommendations supported by a high LOE. The number of guidelines has increased in the past 5 years, but there has been a concomitant decline in the proportion of recommendations supported by a high LOE. Conclusions: There is a general lack of high-quality evidence supporting Chinese CPGs for GIDs, and there are inconsistencies in strong recommendations that have not improved. This study identified areas requiring further research, emphasizing the need to bridge these gaps and promote the conduct of high-quality clinical trials.
引用
收藏
页数:15
相关论文
共 50 条
  • [22] Hemoglobin target levels in chronic renal failure: evidence and clinical practice guidelines
    Lopez, F. Garcia
    Rotaeche, R. Saracho
    NEFROLOGIA, 2007, 27 : 60 - 64
  • [23] Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review
    Cheng-yu Li
    Yao-long Chen
    Jia-yuan Hu
    Min Li
    Xiao-yu Zhang
    Yang Sun
    Rui Zheng
    Shi-qi Chen
    Song-jie Han
    Tian-mai He
    Hong-cai Shang
    Chinese Journal of Integrative Medicine, 2021, 27 : 54 - 61
  • [24] Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review
    Li Cheng-yu
    Chen Yao-long
    Hu Jia-yuan
    Li Min
    Zhang Xiao-yu
    Sun Yang
    Zheng Rui
    Chen Shi-qi
    Han Song-jie
    He Tian-mai
    Shang Hong-cai
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2021, 27 (01) : 54 - 61
  • [25] Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review
    LI Chengyu
    CHEN Yaolong
    HU Jiayuan
    LI Min
    ZHANG Xiaoyu
    SUN Yang
    ZHENG Rui
    CHEN Shiqi
    HAN Songjie
    HE Tianmai
    SHANG Hongcai
    Chinese Journal of Integrative Medicine, 2021, (01) : 54 - 61
  • [26] Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review
    LI Cheng-yu
    CHEN Yao-long
    HU Jia-yuan
    LI Min
    ZHANG Xiao-yu
    SUN Yang
    ZHENG Rui
    CHEN Shi-qi
    HAN Song-jie
    HE Tian-mai
    SHANG Hong-cai
    Chinese Journal of Integrative Medicine, 2021, 27 (01) : 54 - 61
  • [27] Evidence-based clinical practice guidelines for inflammatory bowel disease
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Ueno, Fumiaki
    Matsui, Toshiyuki
    Hirai, Fumihito
    Inoue, Nagamu
    Kato, Jun
    Kobayashi, Kenji
    Kobayashi, Kiyonori
    Koganei, Kazutaka
    Kunisaki, Reiko
    Motoya, Satoshi
    Nagahori, Masakazu
    Nakase, Hiroshi
    Omata, Fumio
    Saruta, Masayuki
    Watanabe, Toshiaki
    Tanaka, Toshiaki
    Kanai, Takanori
    Noguchi, Yoshinori
    Takahashi, Ken-ichi
    Watanabe, Kenji
    Hibi, Toshifumi
    Suzuki, Yasuo
    Watanabe, Mamoru
    Sugano, Kentaro
    Shimosegawa, Tooru
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (03) : 305 - 353
  • [28] Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease
    Kibbi, Nour
    Owen, Joshua L.
    Worley, Brandon
    Wang, Jake X.
    Harikumar, Vishnu
    Downing, Malia B.
    Aasi, Sumaira Z.
    Aung, Phyu P.
    Barker, Christopher A.
    Bolotin, Diana
    Bordeaux, Jeremy S.
    Cartee, Todd, V
    Chandra, Sunandana
    Cho, Nancy L.
    Choi, Jennifer N.
    Chung, Kee Yang
    Cliby, William A.
    Dorigo, Oliver
    Eisen, Daniel B.
    Fujisawa, Yasuhiro
    Golda, Nicholas
    Halfdanarson, Thorvardur R.
    Iavazzo, Christos
    Jiang, Shang I. Brian
    Kanitakis, Jean
    Khan, Ashraf
    Kim, John Y. S.
    Kuzel, Timothy M.
    Lawrence, Naomi
    Leitao, Mario M., Jr.
    MacLean, Allan B.
    Maher, Ian A.
    Mittal, Bharat B.
    Nehal, Kishwer S.
    Ozog, David M.
    Pettaway, Curtis A.
    Ross, Jeffrey S.
    Rossi, Anthony M.
    Servaes, Sabah
    Solomon, Michael J.
    Thomas, Valencia D.
    Tolia, Maria
    Voelzke, Bryan B.
    Waldman, Abigail
    Wong, Michael K.
    Zhou, Youwen
    Arai, Nobuo
    Brackett, Alexandria
    Ibrahim, Sarah A.
    Kang, Bianca Y.
    JAMA ONCOLOGY, 2022, 8 (04) : 618 - 628
  • [29] Evidence-based clinical practice guidelines for inflammatory bowel disease
    Katsuyoshi Matsuoka
    Taku Kobayashi
    Fumiaki Ueno
    Toshiyuki Matsui
    Fumihito Hirai
    Nagamu Inoue
    Jun Kato
    Kenji Kobayashi
    Kiyonori Kobayashi
    Kazutaka Koganei
    Reiko Kunisaki
    Satoshi Motoya
    Masakazu Nagahori
    Hiroshi Nakase
    Fumio Omata
    Masayuki Saruta
    Toshiaki Watanabe
    Toshiaki Tanaka
    Takanori Kanai
    Yoshinori Noguchi
    Ken-ichi Takahashi
    Kenji Watanabe
    Toshifumi Hibi
    Yasuo Suzuki
    Mamoru Watanabe
    Kentaro Sugano
    Tooru Shimosegawa
    Journal of Gastroenterology, 2018, 53 : 305 - 353
  • [30] Clinical Practice Guidelines: Appraising the Evidence
    Buie, W. Donald
    DISEASES OF THE COLON & RECTUM, 2010, 53 (08) : 1107 - 1109